Cardiovascular an Echocardiographic Assessment in Hypertension During Pregnancy

Hypertension During Pregnancy: Cardiovascular & Echocardiographic Assessment: CREATION - P (01)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01068002

Acronym

CREATION-P

Enrollment

Registered

2010-02-12

Start date

2009-06-30

Completion date

2012-09-30

Last updated

2020-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy

Keywords

Hypertension Pregnancy

Brief summary

Cardiovascular & echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women.

Detailed description

Cardiovascular & echocardiographic assessment in pregnant women with hypertension during their pregnancy in comparison to Pregnant normotensive women. Also,comparing echocardiographic parameters in hypertensive pregnant women being treated with either alfa methyl dopa or labetolol.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 60 Years

Healthy volunteers

Inclusion criteria

* hypertension during pregnancy: Chronic or pregnancy induced

Exclusion criteria

* Inability to sign informed consent

Design outcomes

Primary

Measure	Time frame
Hypertension impact on cardiovascular echocardiographic parameters and obstetric parameters in pregnant women with or without treatment	1 year

Secondary

Measure	Time frame
Primary outcome, Impact of alfa methyl dopa and labetolol on cardiovascular parameters in pregnant women	1 Year

Countries

Israel

Outcome results